Back to News
Market Impact: 0.25

ETF Fundamental Report for IWM

IWMNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
ETF Fundamental Report for IWM

Validea's fundamental report on the iShares Russell 2000 ETF (IWM), a Mid-Cap Value ETF, details its exposure to key investment factors. While IWM exhibits a moderate-to-high Value score of 64 and a neutral Momentum score of 47, the analysis critically highlights very low exposure to Quality (7) and Low Volatility (14). This data, alongside its primary sector in Services and industry in Biotechnology & Drugs, provides institutional investors with essential insights into IWM's underlying risk profile and factor biases.

Analysis

A factor analysis of the iShares Russell 2000 ETF (IWM) by Validea reveals a distinct risk profile that aligns with its classification as a Mid-Cap Value ETF, but with significant caveats. The ETF demonstrates a moderately high exposure to the Value factor with a score of 64 out of 99, while its Momentum score of 47 is neutral. Critically, IWM scores extremely low on defensive factors, with a Quality score of just 7 and a Low Volatility score of 14. This profile suggests that the underlying portfolio consists of companies with weaker financial health and higher price volatility compared to the broader market. The ETF's significant allocation to the Services sector and specifically the Biotechnology & Drugs industry likely contributes to these low quality and high volatility characteristics, as biotech is an inherently volatile sector often populated by non-profitable, high-growth firms.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWM0.00
NDAQ0.00

Key Decisions for Investors

  • Investors seeking targeted exposure to the U.S. small-cap value factor may find IWM's Value score of 64 attractive, but must be prepared for the associated risks.
  • The extremely low Quality (7) and Low Volatility (14) scores signal that IWM is not suitable for conservative or risk-averse portfolios, as its holdings are prone to higher price swings and possess weaker fundamental characteristics.
  • Given its factor profile and concentration in volatile sectors like biotechnology, IWM should be carefully balanced with higher-quality or lower-volatility holdings to mitigate portfolio risk.
  • This ETF may be better suited for tactical allocation during periods of high risk appetite rather than as a core, long-term holding in a diversified strategy.